Zelnorm is a drug to treat Irritable Bowel Syndrome (IBS) in women. On March 30, 2007 , the FDA ordered that manufacturer Novartis stop selling Zelnorm due to an increased risk of serious heart problems. Women who used Zelnorm suffered an alarming high number of heart attack, stroke, irregular heart beat, angina, and serious chest pains, which sometimes signaled a “silent” heart attack. Users of Zelnorm received no warnings of these serious side effects until the FDA ordered Zelnorm to be withdrawn from the market.
Comments are closed.